Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Sana Biotechnology, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 155 | 2 | 178 | +25 |
| Shares | 145.5M | 33.2K | 163.7M | +18.2M (+12.5%) |
| Value | $396.9M | $90.7K | $581.8M | +$185.1M (+46.6%) |
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held Sana Biotechnology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (21)
Institutions that held Sana Biotechnology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 702,000 | $1.92M |
| TD Asset Management Inc | 309,034 | $843.7K |
| Skandinaviska Enskilda Banken AB (publ) | 289,273 | $786.8K |
| Brevan Howard Capital Management LP | 260,723 | $711.8K |
| Tudor Investment Corp Et Al | 111,311 | $303.9K |
| Gsa Capital Partners LLP | 102,458 | $280.0K |
| ExodusPoint Capital Management, LP | 71,401 | $195.0K |
| Two Sigma Advisers, LP | 64,570 | $176.3K |
| Bristlecone Advisors, LLC | 50,000 | $136.5K |
| Summit X, LLC | 42,665 | $116.5K |
| Erste Asset Management GmbH | 40,000 | $112.4K |
| Catalyst Funds Management Pty Ltd | 22,600 | $61.7K |
| D. E. Shaw & Co., Inc. | 20,792 | $56.8K |
| WealthPlan Investment Management, LLC | 17,574 | $48.0K |
| Triumph Capital Management | 14,675 | $40.1K |
| National Bank of Canada | 10,800 | $29.5K |
| Bryn Mawr Trust Co | 6,883 | $18.8K |
| Caitong International Asset Management Co., Ltd | 3,952 | $10.8K |
| Skopos Labs, Inc. | 3,064 | $8.37K |
| Raymond James Financial Inc | 477 | $1.30K |
| Bessemer Group Inc | 89 | $0 |
Not filed for Q3 2025 yet (2)
Institutions that held Sana Biotechnology, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Good Life Advisors, LLC | 16,800 | $45.9K |
| CIBC World Markets Corp | 16,439 | $44.9K |